Propranolol's effects on the sleep of infants with hemangiomas: A prospective pilot study.
BISQ
actigraphy
infant sleep
infantile hemangioma
propranolol
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
revised:
18
11
2020
received:
07
08
2020
accepted:
21
11
2020
pubmed:
23
12
2020
medline:
15
5
2021
entrez:
22
12
2020
Statut:
ppublish
Résumé
To assess propranolol's impact on sleep when used in infants and toddlers with infantile hemangioma (80% under 6 months old). Parents and caregivers of infants and toddlers with infantile hemangioma presenting to a tertiary pediatric hospital's dermatology clinic and assessed by their dermatologist as requiring propranolol treatment were invited to participate. All participants completed an extended version of the Brief Infant Sleep Questionnaire (BISQ) prior to propranolol treatment initiation, which acted as the control, and 5 weeks after treatment commencement. Objective data were gathered through actigraphy, which utilizes a small wristwatch-like device that measures sleep-wake patterns, for 1 week prior to initiation and again 5 weeks after commencement. BISQ responses and actigraphy values from the two time points were compared. 55 infants and toddlers (aged 0-2.8 years, 80% under 6 months) were included. Sleep was reported as only a minor problem by most parents 5 weeks after starting propranolol (P = .049). Subgroup analysis of 45 infants <6 months old showed no significant difference in sleep while taking propranolol. Whole cohort BISQ data analysis showed a statistically significant increase in night-time sleep (P = .024), and a decrease in the number (P = .003) and duration of daytime naps (P = .025) following commencement of propranolol. Actigraphy data completed in 10 infants showed no significant difference in sleep quality before and 5 weeks after commencing propranolol. Propranolol did not significantly impair sleep quality and pattern in our cohort of infants and toddlers with infantile hemangioma. Most parents considered the impact on sleep to be only a minor problem.
Substances chimiques
Adrenergic beta-Antagonists
0
Propranolol
9Y8NXQ24VQ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
371-377Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25(2):168-173.
Léauté-Labrèze C, de la Roque ED, Hubiche T, Boralevi F, Thambo J-B, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735-746.
Wang C, Wang Q, Xiang B, Chen S, Xiong F, Ji Y. Effects of propranolol on neurodevelopmental outcomes in patients with infantile Hemangioma: a case-control study. Biomed Res Int. 2018;2018:5821369.
Ji Y, Chen S, Wang Q, et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management. Sci Rep. 2018;8(1):4264.
Bagazgoitia L, Torrelo A, Gutierrez JC, et al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28(2):108-114.
McGee P, Miller S, Black C, Hoey S. Propranolol for infantile hemangioma: a review of current dosing regime in a regional paediatric hospital. Ulster Med J. 2013;82(1):16-20.
Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131(1):128-140.
Bernabeu-Wittel J, Narvaez-Moreno B, de la Torre-Garcia JM, et al. Oral nadolol for children with infantile Hemangiomas and sleep disturbances with oral propranolol. Pediatr Dermatol. 2015;32(6):853-857.
Menezes MD, McCarter R, Greene EA, Bauman NM. Status of propranolol for treatment of infantile hemangioma and description of a randomized clinical trial. Ann Otol Rhinol Laryngol. 2011;120(10):686-695.
Armstrong KL, Quinn RA, Dadds MR. The sleep patterns of normal children. Med J Aust. 1994;161(3):202-205.
Sadeh A. A brief screening questionnaire for infant sleep problems: validation and findings for an internet sample. Pediatrics. 2004;113(6):e570-e577.
Thunstrom M. Severe sleep problems among infants in a normal population in Sweden: prevalence, severity and correlates. Acta Paediatr. 1999;88(12):1356-1363.
Wake M, Morton-Allen E, Poulakis Z, Hiscock H, Gallagher S, Oberklaid F. Prevalence, stability, and outcomes of cry-fuss and sleep problems in the first 2 years of life: prospective community-based study. Pediatrics. 2006;117(3):836-842.
BMedical. Actigraph Spectrum Plus - Philips. BMedical website. https://bmedical.com.au/product/actiwatch-spectrum-plus-philips/. n.d. Accessed October 7, 2020.
Luo Y, Zeng Y, Zhou B, Tang J. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma. Pediatr Dermatol. 2015;32(1):151-152.
Stoschitzky K, Sakotnik A, Lercher P, et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999;55(2):111-115.
Fares A. Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients. J Cardiovasc Dis Res. 2011;2(3):153-155.
Waldhauser F, Weiszenbacher G, Tatzer E, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab. 1988;66(3):648-652.
So K, Buckley P, Adamson TM, Horne RS. Actigraphy correctly predicts sleep behavior in infants who are younger than six months, when compared with polysomnography. Pediatr Res. 2005;58(4):761-765.
So K, Adamson TM, Horne RS. The use of actigraphy for assessment of the development of sleep/wake patterns in infants during the first 12 months of life. J Sleep Res. 2007;16(2):181-187.
Acebo C, Sadeh A, Seifer R, et al. Estimating sleep patterns with activity monitoring in children and adolescents: how many nights are necessary for reliable measures? Sleep. 1999;22(1):95-103.
Iglowstein I, Jenni OG, Molinari L, Largo RH. Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics. 2003;111(2):302-307.
Filippi L, Cavallaro G, Fiorini P, et al. Popranolol concentrations after oral administration in term and preterm neonates. J Matern Fetal Neonatal Med. 2013;26(8):833-840.